Displaying 1–15 of 15 results for Deloitte Life Sciences
Eliminating siloed systems in favor of streamlined applications allows for greater agility and stronger collaboration, enabling pharma to meet the new quality management demands
Multinational survey of pharma execs offers insight on pharmaceutical companies’ growth strategies and risk management in the challenging biologics landscape
For the second consecutive year, Veeva Systems has been named a Leader by Nucleus Research in its 2014 Technology Value Matrix for customer relationship management (CRM).
The company has appointed industry veteran Robert Spignesi as its chief executive officer
Regulation and technology lead the fight against counterfeit pharmaceuticals.
Six Sigma and OpEx now take a back seat to cost-cutting, yet experts say cost reduction will, ultimately, drive the industrys transformation
This white paper by Deloitte Touche Tohmatsu developed in collaboration with the Economist Intelligence Unit (EIU), addresses the growing risks in the life sciences industry and examines how companies will manage and deal with these risks in these changing times.
Technology transfer was once taken for granted as something that would get done anyway. Now its an indicator of manufacturing excellence and a core competency for drug innovators.
While facing an era of new regulatory and marketplace pressures, the life sciences industry is placing more emphasis on the areas of security, information protection and data privacy issues within their organizations. Two key findings: The number of major life sciences firms that employ chief ...
Deloitte Touche Tohmatsu (DTT) surveyed a global representation of leading life sciences executives to determine the security issues facing the industry. The resulting study presents industry trends, security considerations that go beyond the realm of IT, and issues such as business continuity ...
Pharmaceutical processing & engineering: As liability risks increase, drug manufacturers are assuming greater ownership of the “cold chain” for transporting valuable biologics.
SOX is moving from the executive suite down to the plant floor.